Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 9/2014

01.09.2014 | Brief Report

Common Danish standards in prescribing medication for children and adolescents with ADHD

verfasst von: Søren Dalsgaard, Maria Knoth Humlum, Helena Skyt Nielsen, Marianne Simonsen

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Assessing whether symptoms of attention-deficit hyperactivity disorder (ADHD) in children are age-inappropriate is essential. Hence, comparing children within one school grade is problematic and the risk of applying relative standards is inherent. Being young-for-grade increases the likelihood of receiving medication in countries with high prevalence of ADHD medication. We test the same hypothesis in a cohort of 418,396 children and find no difference between children who are young-for-grade and old-for-grade. The Danish system, with its restrictive approach to medication and clear diagnostic guidelines seems to have avoided a systematic bias of ADHD medication in young children reported in other countries.
Literatur
1.
Zurück zum Zitat Dalsgaard S (2013) Attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 22(Suppl 1):S43–S48PubMedCrossRef Dalsgaard S (2013) Attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 22(Suppl 1):S43–S48PubMedCrossRef
2.
Zurück zum Zitat Dalsgaard S, Humlum MK, Nielsen HS, Simonsen M (2012) Relative standards in ADHD diagnoses: the role of specialist behavior. Econ Lett 117:663–665CrossRef Dalsgaard S, Humlum MK, Nielsen HS, Simonsen M (2012) Relative standards in ADHD diagnoses: the role of specialist behavior. Econ Lett 117:663–665CrossRef
3.
Zurück zum Zitat Dalsgaard S, Nielsen HS, Simonsen M (2013) Five-fold increase in national prevalence rates of ADHD medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder and other psychiatric disorders. J Child Adolesc Psychopharmacol 23:432–439PubMedCentralPubMedCrossRef Dalsgaard S, Nielsen HS, Simonsen M (2013) Five-fold increase in national prevalence rates of ADHD medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder and other psychiatric disorders. J Child Adolesc Psychopharmacol 23:432–439PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Evans WN, Morrill MS, Parente ST (2010) Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. J Health Econ 29:657–673PubMedCrossRef Evans WN, Morrill MS, Parente ST (2010) Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children. J Health Econ 29:657–673PubMedCrossRef
6.
Zurück zum Zitat Goodman R, Gledhill J, Ford T (2003) Child psychiatric disorder and relative age within school year: cross sectional survey of large population sample. BMJ 327:472PubMedCentralPubMedCrossRef Goodman R, Gledhill J, Ford T (2003) Child psychiatric disorder and relative age within school year: cross sectional survey of large population sample. BMJ 327:472PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Jinks PC (1964) An investigation into the effect of date of birth on subsequent school performance. Educat Res 6:220–225CrossRef Jinks PC (1964) An investigation into the effect of date of birth on subsequent school performance. Educat Res 6:220–225CrossRef
8.
Zurück zum Zitat Miller AR, Lalonde CE, McGrail KM, Armstrong RW (2001) Prescription of methylphenidate to children and youth, 1990–1996. CMAJ 165:1489–1494PubMedCentralPubMed Miller AR, Lalonde CE, McGrail KM, Armstrong RW (2001) Prescription of methylphenidate to children and youth, 1990–1996. CMAJ 165:1489–1494PubMedCentralPubMed
9.
Zurück zum Zitat Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR (2012) Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 184:755–762PubMedCentralPubMedCrossRef Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR (2012) Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 184:755–762PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Mors O, Perto GP, Mortensen PB (2011) The Danish psychiatric central research register. Scand J Public Health 39:54–57PubMedCrossRef Mors O, Perto GP, Mortensen PB (2011) The Danish psychiatric central research register. Scand J Public Health 39:54–57PubMedCrossRef
11.
Zurück zum Zitat Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB (2006) The Danish civil registration system: a cohort of eight million persons. Dan Med Bull 53:441–449PubMed Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB (2006) The Danish civil registration system: a cohort of eight million persons. Dan Med Bull 53:441–449PubMed
12.
Zurück zum Zitat Wattie N, Cobley S, Baker J (2008) Towards a unified understanding of relative age effects. J Sports Sci 26:1403–1409PubMedCrossRef Wattie N, Cobley S, Baker J (2008) Towards a unified understanding of relative age effects. J Sports Sci 26:1403–1409PubMedCrossRef
13.
Zurück zum Zitat Zoega H, Valdimarsdottir UA, Hernandez-Diaz S (2012) Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study. Pediatrics 130:1012–1018PubMedCentralPubMedCrossRef Zoega H, Valdimarsdottir UA, Hernandez-Diaz S (2012) Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study. Pediatrics 130:1012–1018PubMedCentralPubMedCrossRef
Metadaten
Titel
Common Danish standards in prescribing medication for children and adolescents with ADHD
verfasst von
Søren Dalsgaard
Maria Knoth Humlum
Helena Skyt Nielsen
Marianne Simonsen
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 9/2014
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-013-0508-5

Weitere Artikel der Ausgabe 9/2014

European Child & Adolescent Psychiatry 9/2014 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.